 A ALIMENTARY TRACT AND METABOLISM
|
A01 STOMATOLOGICAL PREPARATIONS
|
A01A STOMATOLOGICAL PREPARATIONS
|
 A01AA Caries prophylactic agents
|
A01AB Antiinfectives and antiseptics for local oral treatment
|
A01AC Corticosteroids for local oral treatment
|
A01AD Other agents for local oral treatment
|
A01AD01 Epinephrine [DG:DG00013]
|
A01AD02 Benzydamine [DG:DG00014]
|
A01AD05 Acetylsalicylic acid [DG:DG00015]
|
 D00109 Aspirin (JP19/USP) <JP>
D05181 Aspirin aluminum (JP19)
D07579 Aspirin calcium salt
D07580 Aspirin DL-lysine (JAN)
D07581 Aspirin magnesium salt
D07582 Aspirin sodium
D12595 Aspirin trelamine (USAN)
D12596 Aspirin trelamine hydrochloride (USAN)
|
A01AD06 Adrenalone [DG:DG00016]
|
A01AD07 Amlexanox
|
A01AD08 Becaplermin
|
A01AD11 Various
|
A02 DRUGS FOR ACID RELATED DISORDERS
|
A02A ANTACIDS
|
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
A02X OTHER DRUGS FOR ACID RELATED DISORDERS
|
A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
A04 ANTIEMETICS AND ANTINAUSEANTS
|
A05 BILE AND LIVER THERAPY
|
A06 DRUGS FOR CONSTIPATION
|
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
|
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
|
A09 DIGESTIVES, INCL. ENZYMES
|
A10 DRUGS USED IN DIABETES
|
A11 VITAMINS
|
A12 MINERAL SUPPLEMENTS
|
A13 TONICS
|
A14 ANABOLIC AGENTS FOR SYSTEMIC USE
|
A15 APPETITE STIMULANTS
|
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
B01 ANTITHROMBOTIC AGENTS
|
B01A ANTITHROMBOTIC AGENTS
|
B01AA Vitamin K antagonists
|
B01AB Heparin group
|
B01AC Platelet aggregation inhibitors excl. heparin
|
B01AC01 Ditazole
|
B01AC02 Cloricromen [DG:DG00154]
|
B01AC03 Picotamide
|
B01AC04 Clopidogrel [DG:DG00155]
|
B01AC05 Ticlopidine [DG:DG00156]
|
B01AC06 Acetylsalicylic acid [DG:DG00015]
|
D00109 Aspirin (JP19/USP) <JP>
D05181 Aspirin aluminum (JP19)
D07579 Aspirin calcium salt
D07580 Aspirin DL-lysine (JAN)
D07581 Aspirin magnesium salt
D07582 Aspirin sodium
D12595 Aspirin trelamine (USAN)
D12596 Aspirin trelamine hydrochloride (USAN)
|
B01AC07 Dipyridamole
|
B01AC08 Carbasalate calcium
|
B01AC09 Epoprostenol [DG:DG00157]
|
B01AC10 Indobufen
|
B01AC11 Iloprost [DG:DG00158]
|
B01AC13 Abciximab
|
B01AC15 Aloxiprin
|
B01AC16 Eptifibatide
|
B01AC17 Tirofiban [DG:DG00159]
|
B01AC18 Triflusal
|
B01AC19 Beraprost [DG:DG00160]
|
B01AC21 Treprostinil [DG:DG00161]
|
B01AC22 Prasugrel
|
B01AC23 Cilostazol
|
B01AC24 Ticagrelor
|
B01AC25 Cangrelor [DG:DG01294]
|
B01AC26 Vorapaxar [DG:DG01349]
|
B01AC27 Selexipag
|
B01AC28 Limaprost [DG:DG01271]
|
B01AC30 Combinations
|
B01AC56 Acetylsalicylic acid, combinations with proton pump inhibitors
|
B01AD Enzymes
|
B01AE Direct thrombin inhibitors [DG:DG01511]
|
B01AF Direct factor Xa inhibitors
|
B01AX Other antithrombotic agents
|
B02 ANTIHEMORRHAGICS
|
B03 ANTIANEMIC PREPARATIONS
|
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
|
B05A BLOOD AND RELATED PRODUCTS
|
B05AA Blood substitutes and plasma protein fractions
|
B05AA01 Albumin [DG:DG00179]
|
D02792 Albumin human (USP) <US>
D02788 Albumin aggregated (USAN)
D05424 Human serum albumin (genetical recombination) (JAN) <JP>
|
B05AA02 Other plasma protein fractions
|
D05526 Plasma protein fraction (USP)
|
B05AA03 Fluorocarbon blood substitutes
|
B05AA05 Dextran [DG:DG00180]
|
D00060 Dextran 1 (USP)
D02047 Dextran sulfate sodium (JAN)
D02141 Iron dextran (USP) <US>
D03343 Dextran sulfate sodium sulfur 5 (JP19)
D06539 Dextran 40 (JP19/USP) <US>
D06540 Dextran 70 (JP19/USP)
D06541 Dextran 75 (USAN)
|
B05AA06 Gelatin agents [DG:DG00181]
|
D00115 Gelatin (JP19/NF) <JP>
D06426 Purified gelatin (JP19)
D06428 Gelatin film, absorbable
D06429 Gelatin sponge, absorbable
|
B05AA07 Hydroxyethylstarch
|
D03335 Hetastarch (USAN) <JP/US>
|
B05AA08 Hemoglobin crosfumaril
|
D04421 Hemoglobin crosfumaril (USAN/INN)
|
B05AA09 Hemoglobin raffimer
|
D04426 Hemoglobin raffimer (USAN)
|
B05AA10 Hemoglobin glutamer (bovine) [DG:DG00182]
|
D04422 Hemoglobin glutamer-200 (bovine) (USAN)
D04423 Hemoglobin glutamer-250 (bovine) (USAN)
|
B05AX Other blood products
|
B05AX01 Erythrocytes
|
B05AX02 Thrombocytes
|
B05AX03 Blood plasma
|
B05AX04 Stem cells from umbilical cord blood
|
D13157 Dorocubicel (USAN/INN)
|
B05B I.V. SOLUTIONS
|
B05C IRRIGATING SOLUTIONS
|
B05D PERITONEAL DIALYTICS
|
B05X I.V. SOLUTION ADDITIVES
|
B05Z HEMODIALYTICS AND HEMOFILTRATES
|
B06 OTHER HEMATOLOGICAL AGENTS
|
|
C CARDIOVASCULAR SYSTEM
|
C01 CARDIAC THERAPY
|
C01A CARDIAC GLYCOSIDES
|
C01B ANTIARRHYTHMICS, CLASS I AND III
|
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
|
C01D VASODILATORS USED IN CARDIAC DISEASES
|
C01DA Organic nitrates
|
C01DB Quinolone vasodilators
|
C01DX Other vasodilators used in cardiac diseases
|
C01DX01 Itramin tosilate
|
C01DX02 Prenylamine [DG:DG00232]
|
C01DX03 Oxyfedrine [DG:DG00233]
|
C01DX04 Benziodarone
|
C01DX05 Carbocromen [DG:DG00234]
|
C01DX06 Hexobendine
|
C01DX07 Etafenone [DG:DG00235]
|
C01DX08 Heptaminol [DG:DG00236]
|
C01DX09 Imolamine
|
C01DX10 Dilazep [DG:DG00237]
|
C01DX11 Trapidil
|
C01DX12 Molsidomine
|
C01DX13 Efloxate
|
C01DX14 Cinepazet
|
C01DX15 Cloridarol
|
C01DX16 Nicorandil
|
C01DX18 Linsidomine
|
C01DX19 Nesiritide [DG:DG00238]
|
C01DX21 Serelaxin
|
D10488 Serelaxin (USAN/INN)
|
C01DX22 Vericiguat
|
C01DX51 Itramin tosilate, combinations
|
C01DX52 Prenylamine, combinations
|
C01DX53 Oxyfedrine, combinations
|
C01DX54 Benziodarone, combinations
|
C01E OTHER CARDIAC PREPARATIONS
|
C01EA Prostaglandins
|
C01EB Other cardiac preparations
|
C01EB02 Camphora [DG:DG00240]
|
C01EB03 Indometacin [DG:DG00241]
|
C01EB04 Crataegus glycosides
|
C01EB05 Creatinolfosfate
|
C01EB06 Fosfocreatine
|
C01EB07 Fructose 1,6-diphosphate
|
C01EB09 Ubidecarenone
|
C01EB10 Adenosine [DG:DG00243]
|
C01EB11 Tiracizine
|
C01EB13 Acadesine
|
C01EB15 Trimetazidine [DG:DG00244]
|
C01EB16 Ibuprofen [DG:DG00245]
|
D00126 Ibuprofen (JP19/USP/INN) <JP/US>
D01122 Ibuprofen piconol (JP19/USAN) <JP>
D04490 Ibuprofen aluminum (USAN)
D06606 Ibuprofen lysine (USAN) <JP/US>
D08058 Ibuprofen arginine salt
D08059 Ibuprofen sodium
D09760 Ibuprofen sodium (USAN)
D12597 Ibuprofen trelamine (USAN)
D12598 Ibuprofen trelamine hydrochloride (USAN)
|
C01EB17 Ivabradine [DG:DG00246]
|
C01EB18 Ranolazine [DG:DG00247]
|
C01EB21 Regadenoson [DG:DG03262]
|
C01EB22 Meldonium
|
C01EB23 Tiazotic acid
|
C01EB24 Mavacamten
|
C01EB25 Acoramidis [DG:DG03143]
|
C01EX Other cardiac combination products
|
C02 ANTIHYPERTENSIVES
|
C03 DIURETICS
|
C04 PERIPHERAL VASODILATORS
|
C05 VASOPROTECTIVES
|
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
|
C05AA Corticosteroids
|
C05AB Antibiotics
|
C05AD Local anesthetics
|
C05AE Muscle relaxants
|
C05AE01 Glyceryl trinitrate
|
D00515 Nitroglycerin (JP19/USP) <JP/US>
|
C05AE02 Isosorbide dinitrate
|
D00516 Isosorbide dinitrate (JP19/USP/INN) <JP/US>
|
C05AE03 Diltiazem [DG:DG00331]
|
D07845 Diltiazem (INN)
D00616 Diltiazem hydrochloride (JP19/USP) <JP/US>
D03830 Diltiazem malate (USAN)
|
C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
|
C05B ANTIVARICOSE THERAPY
|
C05C CAPILLARY STABILIZING AGENTS
|
C05X OTHER VASOPROTECTIVES
|
C07 BETA BLOCKING AGENTS
|
C08 CALCIUM CHANNEL BLOCKERS
|
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
C10 LIPID MODIFYING AGENTS
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
|
G02 OTHER GYNECOLOGICALS
|
G02A UTEROTONICS
|
G02B CONTRACEPTIVES FOR TOPICAL USE
|
G02C OTHER GYNECOLOGICALS
|
G02CA Sympathomimetics, labour repressants
|
G02CB Prolactine inhibitors
|
G02CC Antiinflammatory products for vaginal administration
|
G02CC01 Ibuprofen [DG:DG00245]
|
D00126 Ibuprofen (JP19/USP/INN) <JP/US>
D01122 Ibuprofen piconol (JP19/USAN) <JP>
D04490 Ibuprofen aluminum (USAN)
D06606 Ibuprofen lysine (USAN) <JP/US>
D08058 Ibuprofen arginine salt
D08059 Ibuprofen sodium
D09760 Ibuprofen sodium (USAN)
D12597 Ibuprofen trelamine (USAN)
D12598 Ibuprofen trelamine hydrochloride (USAN)
|
G02CC02 Naproxen [DG:DG00455]
|
G02CC03 Benzydamine [DG:DG00014]
|
G02CC04 Flunoxaprofen
|
G02CX Other gynecologicals
|
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
|
G04 UROLOGICALS
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
L01 ANTINEOPLASTIC AGENTS
|
L01A ALKYLATING AGENTS
|
L01B ANTIMETABOLITES
|
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
|
L01DA Actinomycines
|
L01DB Anthracyclines and related substances [DG:DG01682]
|
L01DB01 Doxorubicin [DG:DG00696]
|
D03899 Doxorubicin (USAN/INN)
D01275 Doxorubicin hydrochloride (JP19/USP) <JP/US>
|
L01DB02 Daunorubicin [DG:DG00697]
|
D07776 Daunorubicin (INN)
D01264 Daunorubicin hydrochloride (JP19/USP) <JP/US>
D10787 Daunorubicin citrate
|
L01DB03 Epirubicin [DG:DG00698]
|
D07901 Epirubicin (INN)
D02214 Epirubicin hydrochloride (JP19/USP) <JP/US>
|
L01DB04 Aclarubicin [DG:DG00699]
|
D02756 Aclarubicin (USAN/INN)
D01911 Aclarubicin hydrochloride (JP19) <JP>
|
L01DB05 Zorubicin
|
D06386 Zorubicin hydrochloride (USAN)
|
L01DB06 Idarubicin [DG:DG00700]
|
D08062 Idarubicin (INN)
D01747 Idarubicin hydrochloride (JP19/USP) <JP/US>
|
L01DB07 Mitoxantrone [DG:DG00701]
|
D08224 Mitoxantrone (INN)
D02166 Mitoxantrone hydrochloride (JAN/USP) <JP/US>
|
L01DB08 Pirarubicin [DG:DG00702]
|
D01885 Pirarubicin (JP19/INN)
D08386 Pirarubicin hydrochloride <JP>
|
L01DB09 Valrubicin
|
D02697 Valrubicin (USP/INN) <US>
|
L01DB10 Amrubicin [DG:DG00703]
|
D08854 Amrubicin (USAN/INN)
D07100 Amrubicin hydrochloride (JAN/USAN) <JP>
|
L01DB11 Pixantrone [DG:DG00704]
|
D05522 Pixantrone (USAN/INN)
D09654 Pixantrone dimaleate (USAN)
|
L01DC Other cytotoxic antibiotics
|
L01E PROTEIN KINASE INHIBITORS
|
L01EA BCR-ABL tyrosine kinase inhibitors [DG:DG03161]
|
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors [DG:DG03162]
|
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors [DG:DG03159]
|
L01ED Anaplastic lymphoma kinase (ALK) inhibitors [DG:DG03136]
|
L01EE Mitogen-activated protein kinase (MEK) inhibitors [DG:DG03137]
|
L01EF Cyclin-dependent kinase (CDK) inhibitors [DG:DG03138]
|
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors [DG:DG01597]
|
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors [DG:DG03158]
|
L01EJ Janus-associated kinase (JAK) inhibitors
|
L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
|
L01EL Bruton's tyrosine kinase (BTK) inhibitors [DG:DG02022]
|
L01EL01 Ibrutinib
|
L01EL02 Acalabrutinib [DG:DG03089]
|
L01EL03 Zanubrutinib
|
L01EL04 Orelabrutinib
|
D12160 Orelabrutinib (USAN/INN)
|
L01EL05 Pirtobrutinib
|
L01EL06 Tirabrutinib [DG:DG03266]
|
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors [DG:DG03139]
|
L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
|
L01EP Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors
|
L01EX Other protein kinase inhibitors
|
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
|
L01FA CD20 (Clusters of Differentiation 20) inhibitors
|
L01FB CD22 (Clusters of Differentiation 22) inhibitors
|
L01FC CD38 (Clusters of Differentiation 38) inhibitors
|
L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
|
L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors
|
L01FF PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
|
L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors
|
L01FX Other monoclonal antibodies and antibody drug conjugates
|
L01FY Combinations of monoclonal antibodies and antibody drug conjugates
|
L01FY01 Pertuzumab and trastuzumab
|
L01FY02 Nivolumab and relatlimab
|
D12334 Nivolumab and relatlimab <US>
|
L01FY03 Prolgolimab and nurulimab
|
L01X OTHER ANTINEOPLASTIC AGENTS
|
L02 ENDOCRINE THERAPY
|
L02A HORMONES AND RELATED AGENTS
|
L02AA Estrogens
|
L02AA01 Diethylstilbestrol [DG:DG00466]
|
D00577 Diethylstilbestrol (USP/INN)
D00946 Diethylstilbestrol diphosphate (USP)
D07826 Hexestrol diphosphate sodium
|
L02AA02 Polyestradiol phosphate
|
D07434 Polyestradiol phosphate (INN)
|
L02AA03 Ethinylestradiol [DG:DG00461]
|
D00554 Ethinyl estradiol (USP) <JP>
D07928 Ethinylestradiol propanesulfonate
|
L02AA04 Fosfestrol [DG:DG00466]
|
D00946 Diethylstilbestrol diphosphate (USP)
D07826 Hexestrol diphosphate sodium
|
L02AB Progestogens
|
L02AB01 Megestrol [DG:DG00457]
|
D08167 Megestrol (INN)
D00952 Megestrol acetate (USP) <US>
|
L02AB02 Medroxyprogesterone [DG:DG00458]
|
D08166 Medroxyprogesterone (INN)
D00951 Medroxyprogesterone acetate (JP19/USP) <JP/US>
|
L02AB03 Gestonorone
|
D01159 Gestonorone caproate (JAN/USAN) <JP>
|
L02AE Gonadotropin releasing hormone analogues
|
L02AE01 Buserelin [DG:DG00729]
|
D07259 Buserelin (INN)
D01831 Buserelin acetate (JAN/USAN) <JP>
|
L02AE02 Leuprorelin [DG:DG00730]
|
D08113 Leuprolide (USAN)
D00989 Leuprolide acetate (USP) <JP/US>
D12337 Leuprolide mesylate (USAN) <US>
|
L02AE03 Goserelin [DG:DG00731]
|
D04405 Goserelin (USAN/INN)
D00573 Goserelin acetate (JP19/USP) <JP/US>
|
L02AE04 Triptorelin [DG:DG00732]
|
D06247 Triptorelin (USAN/INN)
D06248 Triptorelin pamoate (USAN) <US>
D08649 Triptorelin acetate
|
L02AE05 Histrelin [DG:DG00733]
|
D02369 Histrelin (USAN/INN)
D02116 Histrelin acetate <US>
|
L02AE51 Leuprorelin and bicalutamide
|
L02AX Other hormones
|
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
|
L02BA Anti-estrogens [DG:DG01585]
|
L02BB Anti-androgens [DG:DG01624]
|
L02BG Aromatase inhibitors [DG:DG01596]
|
L02BX Other hormone antagonists and related agents
|
L02BX01 Abarelix
|
D02738 Abarelix (USAN/INN)
|
L02BX02 Degarelix [DG:DG00736]
|
D08901 Degarelix (INN/USAN)
D08635 Degarelix acetate (USAN)
D09400 Degarelix acetate (JAN) <JP/US>
|
L02BX03 Abiraterone
|
D09701 Abiraterone acetate (JAN/USP) <JP/US>
|
L02BX04 Relugolix
|
D10888 Relugolix (JAN/USAN/INN) <JP/US>
|
L02BX53 Abiraterone and corticosteroids
|
L03 IMMUNOSTIMULANTS
|
L04 IMMUNOSUPPRESSANTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
M01AA Butylpyrazolidines
|
M01AB Acetic acid derivatives and related substances
|
M01AB01 Indometacin [DG:DG00241]
|
D00141 Indomethacin (USP) <JP/US>
D01565 Indometacin farnesil (JAN) <JP>
D02110 Indomethacin sodium (USP) <JP>
|
M01AB02 Sulindac
|
D00120 Sulindac (JP19/USP/INN) <US>
|
M01AB03 Tolmetin [DG:DG00747]
|
D02355 Tolmetin (USAN/INN)
D00158 Tolmetin sodium (JAN/USP) <US>
|
M01AB04 Zomepirac
|
D06382 Zomepirac sodium (USAN)
|
M01AB05 Diclofenac [DG:DG00441]
|
D07816 Diclofenac (USAN/INN)
D00903 Diclofenac potassium (USP) <US>
D00904 Diclofenac sodium (JP19/USP) <JP/US>
D07817 Diclofenac diethylamine
D07818 Diclofenac epolamine <US>
D07819 Diclofenac calcium
|
M01AB06 Alclofenac
|
D01252 Alclofenac (JAN/USP/INN)
|
M01AB07 Bumadizone [DG:DG00748]
|
D07264 Bumadizone (INN)
D07549 Bumadizone calcium salt hemihydrate
|
M01AB08 Etodolac
|
D00315 Etodolac (JP19/USP/INN) <JP/US>
|
M01AB09 Lonazolac [DG:DG00749]
|
D07265 Lonazolac (INN)
D08142 Lonazolac calcium salt
|
M01AB10 Fentiazac
|
D01975 Fentiazac (JAN/USAN/INN)
|
M01AB11 Acemetacin
|
D01582 Acemetacin (JP19/INN) <JP>
|
M01AB12 Difenpiramide
|
C17720 Difenpiramide
|
M01AB13 Oxametacin
|
D07266 Oxametacin (INN)
|
M01AB14 Proglumetacin [DG:DG00750]
|
D08427 Proglumetacin (INN)
D01765 Proglumetacin maleate (JAN)
|
M01AB15 Ketorolac [DG:DG00751]
|
D08104 Ketorolac (INN)
D00813 Ketorolac tromethamine (USP) <US>
|
M01AB16 Aceclofenac
|
D01545 Aceclofenac (JAN/INN)
|
M01AB17 Bufexamac
|
D01271 Bufexamac (JAN/INN)
|
M01AB51 Indometacin, combinations
|
M01AB55 Diclofenac, combinations
|
D11091 Diclofenac sodium and misoprostol <US>
|
M01AC Oxicams
|
M01AE Propionic acid derivatives
|
M01AE01 Ibuprofen [DG:DG00245]
|
D00126 Ibuprofen (JP19/USP/INN) <JP/US>
D01122 Ibuprofen piconol (JP19/USAN) <JP>
D04490 Ibuprofen aluminum (USAN)
D06606 Ibuprofen lysine (USAN) <JP/US>
D08058 Ibuprofen arginine salt
D08059 Ibuprofen sodium
D09760 Ibuprofen sodium (USAN)
D12597 Ibuprofen trelamine (USAN)
D12598 Ibuprofen trelamine hydrochloride (USAN)
|
M01AE02 Naproxen [DG:DG00455]
|
M01AE03 Ketoprofen [DG:DG00753]
|
M01AE04 Fenoprofen [DG:DG00754]
|
M01AE05 Fenbufen
|
M01AE06 Benoxaprofen
|
M01AE07 Suprofen
|
M01AE08 Pirprofen
|
M01AE09 Flurbiprofen [DG:DG00755]
|
M01AE10 Indoprofen
|
M01AE11 Tiaprofenic acid
|
M01AE12 Oxaprozin
|
M01AE13 Ibuproxam
|
M01AE14 Dexibuprofen [DG:DG00756]
|
M01AE15 Flunoxaprofen
|
M01AE16 Alminoprofen
|
M01AE17 Dexketoprofen
|
M01AE18 Naproxcinod
|
M01AE19 Loxoprofen [DG:DG01251]
|
M01AE20 Pelubiprofen
|
M01AE51 Ibuprofen, combinations
|
M01AE52 Naproxen and esomeprazole
|
M01AE53 Ketoprofen, combinations
|
M01AE56 Naproxen and misoprostol
|
M01AE57 Naproxen and diphenhydramine
|
M01AG Fenamates
|
M01AH Coxibs
|
M01AX Other antiinflammatory and antirheumatic agents, non-steroids
|
M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION
|
M01C SPECIFIC ANTIRHEUMATIC AGENTS
|
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
M02AA Antiinflammatory preparations, non-steroids for topical use
|
M02AA01 Phenylbutazone [DG:DG00745]
|
M02AA02 Mofebutazone
|
M02AA03 Clofezone
|
M02AA04 Oxyphenbutazone [DG:DG00746]
|
M02AA05 Benzydamine [DG:DG00014]
|
M02AA06 Etofenamate
|
M02AA07 Piroxicam [DG:DG00752]
|
M02AA08 Felbinac [DG:DG00764]
|
M02AA09 Bufexamac
|
M02AA10 Ketoprofen [DG:DG00753]
|
M02AA11 Bendazac [DG:DG00765]
|
M02AA12 Naproxen [DG:DG00455]
|
M02AA13 Ibuprofen [DG:DG00245]
|
D00126 Ibuprofen (JP19/USP/INN) <JP/US>
D01122 Ibuprofen piconol (JP19/USAN) <JP>
D04490 Ibuprofen aluminum (USAN)
D06606 Ibuprofen lysine (USAN) <JP/US>
D08058 Ibuprofen arginine salt
D08059 Ibuprofen sodium
D09760 Ibuprofen sodium (USAN)
D12597 Ibuprofen trelamine (USAN)
D12598 Ibuprofen trelamine hydrochloride (USAN)
|
M02AA14 Fentiazac
|
M02AA15 Diclofenac [DG:DG00441]
|
M02AA16 Feprazone
|
M02AA17 Niflumic acid
|
M02AA18 Meclofenamic acid [DG:DG00758]
|
M02AA19 Flurbiprofen [DG:DG00755]
|
M02AA21 Tolmetin [DG:DG00747]
|
M02AA22 Suxibuzone
|
M02AA23 Indometacin [DG:DG00241]
|
M02AA24 Nifenazone
|
M02AA25 Aceclofenac
|
M02AA26 Nimesulide
|
M02AA27 Dexketoprofen
|
M02AA28 Piketoprofen [DG:DG01250]
|
M02AA29 Esflurbiprofen
|
M02AA31 Loxoprofen [DG:DG01251]
|
M02AB Capsaicin and similar agents
|
M02AC Preparations with salicylic acid derivatives
|
M02AX Other topical products for joint and muscular pain
|
M03 MUSCLE RELAXANTS
|
M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
|
M03AA Curare alkaloids [DG:DG01740]
|
M03AB Choline derivatives
|
M03AC Other quaternary ammonium compounds
|
M03AX Other muscle relaxants, peripherally acting agents
|
M03AX01 Botulinum toxin [DG:DG00772]
|
D00783 Botulinum toxin type A (JAN) <JP/US>
D02735 RimabotulinumtoxinB (USAN) <US>
D08957 OnabotulinumtoxinA (USAN) <US>
D09764 AbobotulinumtoxinA (USAN)
D10012 Incobotulinumtoxin A (JAN/USAN) <JP/US>
D10921 DaxibotulinumtoxinA (USAN)
D10949 LetibotulinumtoxinA (USAN) <US>
D10961 NivobotulinumtoxinA (USAN)
D11405 PrabotulinumtoxinA (USAN) <US>
D13185 TrenibotulinumtoxinE (JAN/USAN)
|
M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
|
M03BA Carbamic acid esters
|
M03BA01 Phenprobamate
|
D01824 Phenprobamate (JAN/INN)
|
M03BA02 Carisoprodol
|
D00768 Carisoprodol (JAN/USP/INN) <US>
|
M03BA03 Methocarbamol
|
D00402 Methocarbamol (JAN/USP/INN) <JP/US>
|
M03BA04 Styramate
|
D07274 Styramate (INN)
|
M03BA05 Febarbamate
|
D07275 Febarbamate (INN)
|
M03BA51 Phenprobamate, combinations excl. psycholeptics
|
M03BA52 Carisoprodol, combinations excl. psycholeptics
|
M03BA53 Methocarbamol, combinations excl. psycholeptics
|
M03BA71 Phenprobamate, combinations with psycholeptics
|
M03BA72 Carisoprodol, combinations with psycholeptics
|
M03BA73 Methocarbamol, combinations with psycholeptics
|
M03BB Oxazol, thiazine, and triazine derivatives
|
M03BB02 Chlormezanone
|
D00268 Chlormezanone (JAN/INN)
|
M03BB03 Chlorzoxazone
|
D00771 Chlorzoxazone (JAN/USP/INN) <US>
|
M03BB52 Chlormezanone, combinations excl. psycholeptics
|
M03BB53 Chlorzoxazone, combinations excl. psycholeptics
|
M03BB72 Chlormezanone, combinations with psycholeptics
|
M03BB73 Chlorzoxazone, combinations with psycholeptics
|
M03BC Ethers, chemically close to antihistamines
|
M03BC01 Orphenadrine (citrate)
|
D00774 Orphenadrine citrate (USP) <US>
|
M03BC51 Orphenadrine, combinations
|
M03BX Other centrally acting agents
|
M03BX01 Baclofen
|
D00241 Baclofen (JP19/USP/INN) <JP/US>
|
M03BX02 Tizanidine [DG:DG00773]
|
D08611 Tizanidine (INN)
D00776 Tizanidine hydrochloride (JP19/USP) <JP/US>
|
M03BX03 Pridinol [DG:DG00774]
|
D08418 Pridinol (INN)
D02064 Pridinol mesilate (JAN) <JP>
D08419 Pridinol hydrochloride
|
M03BX04 Tolperisone [DG:DG00766]
|
D08617 Tolperisone (INN)
D01507 Tolperisone hydrochloride (JP19)
|
M03BX05 Thiocolchicoside
|
D07276 Thiocolchicoside (INN)
|
M03BX06 Mephenesin
|
D02595 Mephenesin (INN)
|
M03BX07 Tetrazepam
|
D07277 Tetrazepam (INN)
|
M03BX08 Cyclobenzaprine [DG:DG00775]
|
D07758 Cyclobenzaprine (INN)
D00772 Cyclobenzaprine hydrochloride (USP) <US>
|
M03BX09 Eperisone [DG:DG00776]
|
D07898 Eperisone (INN)
D01671 Eperisone hydrochloride (JP19) <JP>
|
M03BX30 Fenyramidol [DG:DG00777]
|
D07953 Fenyramidol (INN)
D00755 Phenyramidol hydrochloride (USAN)
|
M03BX53 Pridinol, combinations
|
M03BX55 Thiocolchicoside, combinations
|
M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
|
M03CA Dantrolene and derivatives
|
M03CA01 Dantrolene [DG:DG00778]
|
D02347 Dantrolene (USAN/INN)
D02274 Dantrolene sodium (USP) <JP/US>
|
M04 ANTIGOUT PREPARATIONS
|
M05 DRUGS FOR TREATMENT OF BONE DISEASES
|
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
N01 ANESTHETICS
|
N02 ANALGESICS
|
N02A OPIOIDS
|
N02B OTHER ANALGESICS AND ANTIPYRETICS
|
N02BA Salicylic acid and derivatives
|
N02BA01 Acetylsalicylic acid [DG:DG00015]
|
D00109 Aspirin (JP19/USP) <JP>
D05181 Aspirin aluminum (JP19)
D07579 Aspirin calcium salt
D07580 Aspirin DL-lysine (JAN)
D07581 Aspirin magnesium salt
D07582 Aspirin sodium
D12595 Aspirin trelamine (USAN)
D12596 Aspirin trelamine hydrochloride (USAN)
|
N02BA02 Aloxiprin
|
N02BA03 Choline salicylate
|
N02BA04 Sodium salicylate
|
N02BA05 Salicylamide
|
N02BA06 Salsalate
|
N02BA07 Ethenzamide
|
N02BA08 Morpholine salicylate
|
N02BA09 Dipyrocetyl
|
N02BA10 Benorilate
|
N02BA11 Diflunisal
|
N02BA12 Potassium salicylate
|
N02BA14 Guacetisal
|
N02BA15 Carbasalate calcium
|
N02BA16 Imidazole salicylate
|
N02BA51 Acetylsalicylic acid, combinations excl. psycholeptics
|
N02BA55 Salicylamide, combinations excl. psycholeptics
|
N02BA57 Ethenzamide, combinations excl. psycholeptics
|
N02BA59 Dipyrocetyl, combinations excl. psycholeptics
|
N02BA65 Carbasalate calcium combinations excl. psycholeptics
|
N02BA67 Magnesium salicylate, combinations excl. psycholeptics
|
N02BA71 Acetylsalicylic acid, combinations with psycholeptics
|
N02BA75 Salicylamide, combinations with psycholeptics
|
N02BA77 Ethenzamide, combinations with psycholeptics
|
N02BA79 Dipyrocetyl, combinations with psycholeptics
|
N02BB Pyrazolones
|
N02BE Anilides
|
N02BF Gabapentinoids [DG:DG01574]
|
N02BG Other analgesics and antipyretics
|
N02C ANTIMIGRAINE PREPARATIONS
|
N02CA Ergot alkaloids
|
N02CB Corticosteroid derivatives
|
N02CC Selective serotonin (5HT1) agonists [DG:DG01943]
|
N02CD Calcitonin gene-related peptide (CGRP) antagonists
|
N02CD01 Erenumab
|
D10928 Erenumab (USAN/INN) <JP/US>
|
N02CD02 Galcanezumab
|
D10936 Galcanezumab (USAN/INN) <JP/US>
|
N02CD03 Fremanezumab
|
D11055 Fremanezumab (USAN/INN) <JP/US>
|
N02CD04 Ubrogepant
|
D10673 Ubrogepant (USAN/INN) <US>
|
N02CD05 Eptinezumab
|
D11303 Eptinezumab (USAN) <US>
|
N02CD06 Rimegepant [DG:DG01845]
|
D10662 Rimegepant (USAN/INN)
D10663 Rimegepant sulfate (USAN) <JP/US>
|
N02CD07 Atogepant [DG:DG03330]
|
D11313 Atogepant (USAN) <US>
D13026 Atogepant hydrate (JAN) <JP>
|
N02CD08 Zavegepant [DG:DG03122]
|
D11898 Zavegepant (USAN)
D11899 Zavegepant hydrochloride (USAN) <US>
|
N02CX Other antimigraine preparations
|
N03 ANTIEPILEPTICS
|
N04 ANTI-PARKINSON DRUGS
|
N05 PSYCHOLEPTICS
|
N05A ANTIPSYCHOTICS
|
N05B ANXIOLYTICS
|
N05C HYPNOTICS AND SEDATIVES
|
N05CA Barbiturates, plain
|
N05CB Barbiturates, combinations
|
N05CC Aldehydes and derivatives
|
N05CD Benzodiazepine derivatives
|
N05CE Piperidinedione derivatives
|
N05CF Benzodiazepine related drugs
|
N05CF01 Zopiclone
|
D01372 Zopiclone (JP19/INN) <JP>
|
N05CF02 Zolpidem [DG:DG00922]
|
D08690 Zolpidem (INN)
D00706 Zolpidem tartrate (JP19/USP) <JP/US>
|
N05CF03 Zaleplon
|
D00530 Zaleplon (JAN/USP/INN) <US>
|
N05CF04 Eszopiclone
|
D02624 Eszopiclone (JAN/USP/INN) <JP/US>
|
N05CH Melatonin receptor agonists
|
N05CJ Orexin receptor antagonists
|
N05CM Other hypnotics and sedatives
|
N05CX Hypnotics and sedatives in combination, excl. barbiturates
|
N06 PSYCHOANALEPTICS
|
N07 OTHER NERVOUS SYSTEM DRUGS
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
P01 ANTIPROTOZOALS
|
P02 ANTHELMINTICS
|
P02B ANTITREMATODALS
|
P02BA Quinoline derivatives and related substances
|
P02BA01 Praziquantel
|
D00471 Praziquantel (JAN/USP/INN) <JP/US>
|
P02BA02 Oxamniquine
|
D00460 Oxamniquine (USAN/INN)
|
P02BA03 Arpraziquantel
|
D12741 Arpraziquantel (INN)
|
P02BB Organophosphorous compounds
|
P02BX Other antitrematodal agents
|
P02C ANTINEMATODAL AGENTS
|
P02D ANTICESTODALS
|
P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
R01 NASAL PREPARATIONS
|
R02 THROAT PREPARATIONS
|
R02A THROAT PREPARATIONS
|
R02AA Antiseptics
|
R02AB Antibiotics
|
R02AD Anesthetics, local
|
R02AX Other throat preparations
|
R02AX01 Flurbiprofen [DG:DG00755]
|
R02AX02 Ibuprofen [DG:DG00245]
|
D00126 Ibuprofen (JP19/USP/INN) <JP/US>
D01122 Ibuprofen piconol (JP19/USAN) <JP>
D04490 Ibuprofen aluminum (USAN)
D06606 Ibuprofen lysine (USAN) <JP/US>
D08058 Ibuprofen arginine salt
D08059 Ibuprofen sodium
D09760 Ibuprofen sodium (USAN)
D12597 Ibuprofen trelamine (USAN)
D12598 Ibuprofen trelamine hydrochloride (USAN)
|
R02AX03 Benzydamine [DG:DG00014]
|
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
R05 COUGH AND COLD PREPARATIONS
|
R06 ANTIHISTAMINES FOR SYSTEMIC USE
|
R07 OTHER RESPIRATORY SYSTEM PRODUCTS
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification